FDA approves Glaxo’s Hiberix vaccine

GlaxoSmithKline P.L.C. has won swift approval from the federal government to produce and sell a booster vaccine against Haemophilus influenzae type b, which should help eliminate shortages of the shot against the deadly disease.

Copyright PHILY - Philly.com
Contact Us